In mice with monobenzone-induced vitiligo, LBP treatment attenuated the symptoms of a vitiligo-like skin disease, inhibited infiltration of CD8+ T cells and reduced activity of the STAT3-Hsp70-CXCL9/CXCL10 signalling pathway. The gene discussed is STAT3; the disease is vitiligo.